Related references
Note: Only part of the references are listed.Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responses
Han Zeng et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Potential cytotoxic and anti-metastatic effects of berberine on gynaecological cancers with drug-associated resistance
Hamed Mortazavi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Interleukin-22 promotes development of malignant lesions in a mouse model of spontaneous breast cancer
Gajendra K. Katara et al.
MOLECULAR ONCOLOGY (2020)
The Interleukin 22 Pathway Interacts with Mutant KRAS to Promote Poor Prognosis in Colon Cancer
Sarah McCuaig et al.
CLINICAL CANCER RESEARCH (2020)
Potential inhibitory effect of lycopene on prostate cancer
Mahdi Mirahmadi et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
In vivo study: Th1-Th17 reduction in pristane-induced systemic lupus erythematosus mice after treatment with tolerogenic Lactobacillus probiotics
Fatemeh Mardani et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation
Wenjun Ouyang et al.
IMMUNITY (2019)
Role of Th22 cells in Helicobacter pylori-related gastritis and peptic ulcer diseases
Ahmad Sanaii et al.
MOLECULAR BIOLOGY REPORTS (2019)
Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study
S. Adams et al.
ANNALS OF ONCOLOGY (2019)
Analysis of Th22, Th17 and CD4+ cells co-producing IL-17/IL-22 at different stages of human colon cancer
Hassan Doulabi et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Study of serum bactericidal and splenic activity of Total-OMP-CagA combination from Brucella abortus and Helicobacter pylori in BALB/c mouse model
Amir Hossein Abadi et al.
MICROBIAL PATHOGENESIS (2018)
Interleukin-22, a potent target for treatment of non-autoimmune diseases
Yue Zheng et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Th22 Cells Form a Distinct Th Lineage from Th17 Cells In Vitro with Unique Transcriptional Properties and Tbet-Dependent Th1 Plasticity
Maximilian W. Plank et al.
JOURNAL OF IMMUNOLOGY (2017)
Intra-tumoral IFN-γ-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer
Elena Niccolai et al.
CLINICAL SCIENCE (2016)
IL-21 and IL-21 receptor in the immunopathogenesis of multiple sclerosis
Ghasem Ghalamfarsa et al.
JOURNAL OF IMMUNOTOXICOLOGY (2016)
Th22 cells control colon tumorigenesis through STAT3 and Polycomb Repression complex 2 signaling
Danfeng Sun et al.
ONCOIMMUNOLOGY (2016)
Interleukin-22 promotes lung cancer cell proliferation and migration via the IL-22R1/STAT3 and IL-22R1/AKT signaling pathways
Yi Bi et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2016)
Interleukin-22: Immunobiology and Pathology
Jarrod A. Dudakov et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
The existence of Th22, pure Th17 and Th1 cells in CIN and Cervical Cancer along with their frequency variation in different stages of cervical cancer
Wenjing Zhang et al.
BMC CANCER (2015)
Inflammation and cancer: advances and new agents
Shanthini M. Crusz et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Th22 cell accumulation is associated with colorectal cancer development
Yong-Hong Huang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Evaluation of anti-cancer and immunomodulatory effects of carnosol in a Balb/c WEHI-164 fibrosarcoma model
Maryam Rahnama et al.
JOURNAL OF IMMUNOTOXICOLOGY (2015)
High Expression of Interleukin-22 and Its Receptor Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma
Zhang Wen et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
IL-22 produced by cancer-associated fibroblasts promotes gastric cancer cell invasion via STAT3 and ERK signaling
H. Fukui et al.
BRITISH JOURNAL OF CANCER (2014)
The role of the IL-22/IL-22R1 axis in cancer
Chrissie Lim et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2014)
IL-22+CD4+ T Cells Promote Colorectal Cancer Stemness via STAT3 Transcription Factor Activation and Induction of the Methyltransferase DOT1L
Ilona Kryczek et al.
IMMUNITY (2014)
Therapeutic opportunities of the IL-22-IL-22R1 system
Robert Sabat et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
IL-21 induces IL-22 production in CD4+T cells
Ada Yeste et al.
NATURE COMMUNICATIONS (2014)
Chronic Inflammation and Cytokines in the Tumor Microenvironment
Glauben Landskron et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Recognition strategies of group 3 innate lymphoid cells
Monica Killig et al.
FRONTIERS IN IMMUNOLOGY (2014)
EXPRESSION PATTERNS OF TH1/TH2 TRANSCRIPTION FACTORS IN PATIENTS WITH GUTTATE PSORIASIS
Elaheh Vanaki et al.
ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA (2013)
Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model
Stefanie Kirchberger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Pro-inflammatory signaling by IL-10 and IL-22: bad habit stirred up by interferons?
Heiko Muehl
FRONTIERS IN IMMUNOLOGY (2013)
Increased intratumoral IL-22-producing CD4+ T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival
Yuan Zhuang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Th22 Cells Are an Important Source of IL-22 for Host Protection against Enteropathogenic Bacteria
Rajatava Basu et al.
IMMUNITY (2012)
STAT3 signal transduction through interleukin-22 in oral squamous cell carcinoma
Lutfun Naher et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Increased Circulating Th22 and Th17 Cells are Associated with Tumor Progression and Patient Survival in Human Gastric Cancer
Tao Liu et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine
Samuel Huber et al.
NATURE (2012)
Interleukin-22 Promotes Human Hepatocellular Carcinoma by Activation of STAT3
Runqiu Jiang et al.
HEPATOLOGY (2011)
Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention
Ning Zhang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Interleukin-22 Suppresses the Growth of A498 Renal Cell Carcinoma Cells via Regulation of STAT1 Pathway
Fengbo Zhang et al.
PLOS ONE (2011)
High Fat Diet Induces Formation of Spontaneous Liposarcoma in Mouse Adipose Tissue with Overexpression of Interleukin 22
Zheng Wang et al.
PLOS ONE (2011)
Interleukin-22: A cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection
Ellen Witte et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A
Gregory F. Sonnenberg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
IL-22 Induces an Acute-Phase Response
Spencer C. Liang et al.
JOURNAL OF IMMUNOLOGY (2010)
Adoptive immunotherapy of cancer using CD4+ T cells
Pawel Muranski et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
IL-22-producing T22 T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells
Kristine E. Nograles et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17
Melba Munoz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells
Sara Trifari et al.
NATURE IMMUNOLOGY (2009)
Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells
Thomas Duhen et al.
NATURE IMMUNOLOGY (2009)
IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia
Shean J. Aujla et al.
NATURE MEDICINE (2008)
Adaptive immunity maintains occult cancer in an equilibrium state
Catherine M. Koebel et al.
NATURE (2007)
Interleukin-22 but not interleukin-17 provides protection to Hepatocytes during acute liver inflammation
Lauren A. Zenewicz et al.
IMMUNITY (2007)
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Yan Zheng et al.
NATURE (2007)
IL-22-mediated tumor growth reduction correlates with inhibition of ERK1/2 and AKT phosphorylation and induction of cell cycle arrest in the G2-M phase
Georg F. Weber et al.
JOURNAL OF IMMUNOLOGY (2006)
IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes:: a potential role in psoriasis
Kerstin Wolk et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Expression of interleukin-22 in rheumatoid arthritis - Potential role as a proinflammatory cytokine
H Ikeuchi et al.
ARTHRITIS AND RHEUMATISM (2005)
Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts
A Andoh et al.
GASTROENTEROLOGY (2005)
The immunobiology of cancer immunosurveillance and immunoediting
GP Dunn et al.
IMMUNITY (2004)
Expression of interleukin-22 in murine carcinoma cells did not influence tumour growth in vivo but did improve survival of the inoculated hosts
H Nagakawa et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2004)
Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation
S Radaeva et al.
HEPATOLOGY (2004)
Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line - Pathways that are shared with and distinct from IL-10
D Lejeune et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity
SV Kotenko et al.
JOURNAL OF IMMUNOLOGY (2001)
Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22
L Dumoutier et al.
JOURNAL OF IMMUNOLOGY (2001)
Identification of the functional interleukin-22 (IL-22) receptor complex -: The IL-10R2 chain (IL-10Rβ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes
SV Kotenko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R
MH Xie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Human interleukin-10-related T cell-derived inducible factor: Molecular cloning and functional characterization as an hepatocyte-stimulating factor
L Dumoutier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
